Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Medicinal Chemistry (Shariqah (United Arab Emirates))|February 28, 2018
Emerging Roles of Purinergic Signaling in DiabetesCarmen Fotino, Diego Dal Ben, Elena AdinolfiMolecules (Basel, Switzerland)|February 25, 2023
Machine Learning Scoring Functions for Drug Discovery from Experimental and Computer-Generated Protein-Ligand Structures: Towards Per-Target Scoring FunctionsFrancesco Pellicani, Diego Dal Ben, Andrea Perali, et al.Advances in Protein Chemistry and Structural Biology|April 3, 2016
P2X7 Receptor as a Therapeutic TargetElena De Marchi, Elisa Orioli, Diego Dal Ben, et al.In Silico Pharmacology|December 16, 2014
Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptorDiego Dal Ben, Michela Buccioni, Catia Lambertucci, et al.Bioorganic & Medicinal Chemistry|September 9, 2008
Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugsIppolito Antonini, Rosaria Volpini, Diego Dal Ben, et al.Current Topics in Medicinal Chemistry|April 8, 2010
Adenosine receptor modeling: what does the A2A crystal structure tell us?Diego Dal Ben, Catia Lambertucci, Gabriella Marucci, et al.Current Medicinal Chemistry|December 18, 2014
Medicinal chemistry of P2X receptors: agonists and orthosteric antagonistsCatia Lambertucci, Diego Dal Ben, Michela Buccioni, et al.European Journal of Medicinal Chemistry|December 3, 2014
Purinergic P2X receptors: structural models and analysis of ligand-target interactionDiego Dal Ben, Michela Buccioni, Catia Lambertucci, et al.Frontiers in Pharmacology|March 30, 2018
Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal DiseasesDiego Dal Ben, Luca Antonioli, Catia Lambertucci, et al.Neuropharmacology|October 9, 2020
Efficacy of acetylcholinesterase inhibitors in Alzheimer's diseaseGabriella Marucci, Michela Buccioni, Diego Dal Ben, et al.Pageof 10